Correlation Between Aquestive Therapeutics and 54866NBP3

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aquestive Therapeutics and 54866NBP3 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aquestive Therapeutics and 54866NBP3 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aquestive Therapeutics and US54866NBP33, you can compare the effects of market volatilities on Aquestive Therapeutics and 54866NBP3 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aquestive Therapeutics with a short position of 54866NBP3. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aquestive Therapeutics and 54866NBP3.

Diversification Opportunities for Aquestive Therapeutics and 54866NBP3

-0.15
  Correlation Coefficient

Good diversification

The 3 months correlation between Aquestive and 54866NBP3 is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Aquestive Therapeutics and US54866NBP33 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on US54866NBP33 and Aquestive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aquestive Therapeutics are associated (or correlated) with 54866NBP3. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of US54866NBP33 has no effect on the direction of Aquestive Therapeutics i.e., Aquestive Therapeutics and 54866NBP3 go up and down completely randomly.

Pair Corralation between Aquestive Therapeutics and 54866NBP3

Given the investment horizon of 90 days Aquestive Therapeutics is expected to under-perform the 54866NBP3. In addition to that, Aquestive Therapeutics is 7.38 times more volatile than US54866NBP33. It trades about -0.26 of its total potential returns per unit of risk. US54866NBP33 is currently generating about -0.31 per unit of volatility. If you would invest  10,592  in US54866NBP33 on September 14, 2024 and sell it today you would lose (106.00) from holding US54866NBP33 or give up 1.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy28.57%
ValuesDaily Returns

Aquestive Therapeutics  vs.  US54866NBP33

 Performance 
       Timeline  
Aquestive Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aquestive Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
US54866NBP33 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days US54866NBP33 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Bond's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for US54866NBP33 investors.

Aquestive Therapeutics and 54866NBP3 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aquestive Therapeutics and 54866NBP3

The main advantage of trading using opposite Aquestive Therapeutics and 54866NBP3 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aquestive Therapeutics position performs unexpectedly, 54866NBP3 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 54866NBP3 will offset losses from the drop in 54866NBP3's long position.
The idea behind Aquestive Therapeutics and US54866NBP33 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges